<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<!-- Template generated by Exclaimer Signature Manager Exchange Edition on 01:36:53 Monday, 26 July 2021 -->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<style type="text/css">P.ImprintUniqueID {
MARGIN: 0cm 0cm 0pt
}
LI.ImprintUniqueID {
MARGIN: 0cm 0cm 0pt
}
DIV.ImprintUniqueID {
MARGIN: 0cm 0cm 0pt
}
TABLE.ImprintUniqueIDTable {
MARGIN: 0cm 0cm 0pt
}
DIV.Section1 {
page: Section1
}
</style>
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Segoe Print";
panose-1:2 0 6 0 0 0 0 0 0 0;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
span.EmailStyle18
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle19
{mso-style-type:personal-reply;
color:black;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<p class="ImprintUniqueID"></p>
<div class="WordSection1">
<p class="MsoNormal"><span style="color:black">At Salem, we assign the dose to the specific unit.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:black"><o:p> </o:p></span></p>
<div>
<p class="MsoNormal"><span style="color:black">Linda Doll<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:black">Salem ALARA<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:black">856-339-2057<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;color:black">Toast Masters President – Atomic Orators<o:p></o:p></span></p>
</div>
<p class="MsoNormal"><span style="color:black"><o:p> </o:p></span></p>
<div></div>
</div>
<p></p>
<table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" class="ImprintUniqueIDTable" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td><a href="http://www.pseg.com" target=""><img width="228" height="59" style="margin-bottom: 0px; border: 0px Solid ; " src="https://www.pseg.com/images/global/email/PSEG_emailsignature_PSEGw-tag_version2.png"></a></td>
</tr>
<tr>
<td style="PADDING-BOTTOM: 5px; PADDING-LEFT: 72px; PADDING-TOP: 5px">
<table cellpadding="0" cellspacing="0" style=" text-align: center; vertical-align: top; " class="c9fd7158-d8e3-482f-b06a-750a6b928070Table">
<tbody>
<tr style="text-align: center; vertical-align: top; ">
<td align="Center" style="padding-right: 16px; "><a href="http://www.facebook.com/pseg" target=""><img width="25" height="25" style="border: 0px Solid ; " src="https://www.pseg.com/images/global/facebookIcon.PNG" title="Facebook" alt="http://facebook.com/pseg"></a></td>
<td align="Center" style="padding-right: 16px; "><a href="http://www.twitter.com/PSEGnews" target=""><img width="25" height="25" style="border: 0px Solid ; " src="https://www.pseg.com/images/global/footericon-twiter.PNG" title="Twitter" alt="Twitter"></a></td>
<td align="Center" style="padding-right: 16px; "><a href="http://www.linkedin.com/company/pseg" target=""><img width="25" height="25" style="border: 0px Solid ; " src="https://www.pseg.com/images/global/linkedin_logo.png" title="LinkedIn" alt="LinkedIn"></a></td>
<td align="Center" style=""><a href="http://energizepseg.com/" target=""><img width="25" height="25" style="border: 0px Solid ; " src="https://www.pseg.com/images/global/WP_LOGOgrey.png" title="Wordpress"></a></td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
<p class="ImprintUniqueID"><font style="FONT-SIZE: 1pt" color="#ffffff">PSEGSC</font><br>
</p>
<div class="WordSection1">
<div>
<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b>From:</b> Global <global-bounces@list.rpalara.org> <b>On Behalf Of
</b>Meldrum III, William H<br>
<b>Sent:</b> Monday, July 26, 2021 12:57 PM<br>
<b>To:</b> global@list.rpalara.org<br>
<b>Subject:</b> [EXTERNAL] [Global] Dry Cask Dose Allocation<o:p></o:p></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<div>
<div align="center">
<table class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" style="background:yellow;border:outset black 2.25pt">
<tbody>
<tr>
<td style="border:inset black 1.0pt;padding:0in 0in 0in 0in">
<table class="MsoNormalTable" border="0" cellpadding="0">
<tbody>
<tr>
<td width="33%" style="width:33.0%;padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal" align="center" style="text-align:center"><b><span style="font-size:12.0pt;font-family:"Times New Roman",serif;color:red">***CAUTION***</span></b><span style="font-size:12.0pt;font-family:"Times New Roman",serif"><o:p></o:p></span></p>
</td>
<td width="33%" style="width:33.0%;padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal" align="center" style="text-align:center"><b><span style="font-size:12.0pt;font-family:"Times New Roman",serif;color:red">***CAUTION***</span></b><span style="font-size:12.0pt;font-family:"Times New Roman",serif"><o:p></o:p></span></p>
</td>
<td width="33%" style="width:33.0%;padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal" align="center" style="text-align:center"><b><span style="font-size:12.0pt;font-family:"Times New Roman",serif;color:red">***CAUTION***</span></b><span style="font-size:12.0pt;font-family:"Times New Roman",serif"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td width="100%" colspan="3" style="width:100.0%;padding:.75pt .75pt .75pt .75pt">
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:"Times New Roman",serif">This e-mail is from an
<b>EXTERNAL </b>address. The actual sender is (<a href="mailto:global-bounces@list.rpalara.org">global-bounces@list.rpalara.org</a>) which may be different from the display address in the From: field. Be cautious of clicking on links or opening attachments.
Suspicious? Report it via the Report Phishing button. On mobile phones, forward message to Cyber Security.<o:p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</div>
<p class="MsoNormal" style="margin-bottom:12.0pt"><span style="font-size:12.0pt;font-family:"Times New Roman",serif"><o:p> </o:p></span></p>
</div>
<p class="MsoNormal">For those with multi-unit sites, do you assign dose from Dry Cask evolutions for CRE purposes to a specific unit, or do you divide it evenly among units?<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b><span style="font-family:"Segoe Print"">Bill Meldrum</span></b><span style="font-family:"Segoe Print""><o:p></o:p></span></p>
<p class="MsoNormal">Oconee Nuclear Station<o:p></o:p></p>
<p class="MsoNormal">RP/ALARA<o:p></o:p></p>
<p class="MsoNormal">x 3204<o:p></o:p></p>
<p class="MsoNormal"><a href="tel:864-873-3204" target="_blank"><span style="color:blue">864-873-3204</span></a><o:p></o:p></p>
<p class="MsoNormal">Cell 803-229-2204<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<p></p>
<DIV>
The information contained in this e-mail, including any attachment(s), is intended solely for use by the named addressee(s). If you are not the intended recipient, or a person designated as responsible for delivering such messages to the intended recipient, you are not authorized to disclose, copy, distribute or retain this message, in whole or in part, without written authorization from PSEG. This e-mail may contain proprietary, confidential or privileged information. If you have received this message in error, please notify the sender immediately. This notice is included in all e-mail messages leaving PSEG. Thank you for your cooperation.<BR>
</DIV></body>
</html>